Actinium Pharmaceuticals, Inc. (ATNM)
R&D Expenses
$18.74M
TTM · Period ending: · USD
ATNM R&D Expenses
Latest reported$18.74Mperiod ending
Latest reported$18.74Mperiod ending
ATNM TTM R&D Expenses ($0.00 → $18.74M)
TTM R&D Expenses
High-resolution chart · PNG
ATNM r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 18,738,000 | |
| 18,240,000 | |
| 21,739,000 | |
| 21,434,000 | |
| 26,758,000 | |
| 30,515,000 | |
| 29,234,000 | |
| 32,546,000 | |
| 34,396,000 | |
| 36,632,000 | |
| 38,062,000 | |
| 37,315,000 | |
| 32,443,000 | |
| 26,053,000 | |
| 22,436,000 | |
| 20,543,000 | |
| 18,701,000 | |
| 17,850,000 | |
| 17,894,000 | |
| 17,254,000 | |
| 16,334,000 | |
| 16,211,000 | |
| 16,086,000 | |
| 14,820,660 | |
| 15,862,660 | |
| 16,364,660 | |
| 16,549,660 | |
| 18,261,000 | |
| 17,652,000 | |
| 16,967,000 | |
| 17,094,000 | |
| 15,681,000 | |
| 16,417,000 | |
| 17,471,000 | |
| 17,512,000 | |
| 17,742,000 | |
| 18,471,000 | |
| 18,240,000 | |
| 17,501,000 | |
| 16,196,000 | |
| 13,338,000 | |
| 13,028,000 | |
| 13,312,000 | |
| 14,746,000 | |
| 15,691,000 | |
| 13,855,000 | |
| 12,267,000 | |
| 8,529,659 | |
| 5,534,891 | |
| 4,042,153 | |
| 2,667,153 | |
| 3,535,494 | |
| 4,434,262 | |
| 4,526,272 | |
| 3,440,272 | |
| 2,278,272 | |
| 601,272 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |